“Bedaquiline-a Potential Inhibitor of COVID-19 Main Protease Based on Molecular Docking”. International Journal of Research in Pharmacology & Pharmacotherapeutics, vol. 9, no. 2, Mar. 2021, pp. 136-44, https://doi.org/10.61096/ijrpp.v9.iss2.2020.136-144.